Evidence for a direct role of the disease modifier SCNM1 in splicing

Human Molecular Genetics

Volumn 16, Issue 20, 2007, Pages 2506-2516

  Howell, Viive M ^a   Jones, Julie M ^a   Bergren, Sarah K ^a   Li, Li ^a   Billi, Allison C ^a   Avenarius, Matthew R ^a   Meisler, Miriam H ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION TRANSPORT PROTEIN; NUCLEAR PROTEIN; PROTEIN LUC7L2; PROTEIN SCNM1; PROTEIN SM; PROTEIN U1 70K; SMALL NUCLEAR RIBONUCLEOPROTEIN; SODIUM CHANNEL MODIFIER 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; DISEASE SEVERITY; EMBRYO; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SPLICEOSOME; TWO HYBRID SYSTEM; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; GENETIC DISEASES, INBORN; HUMANS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; POLYADENYLATION; PROTEIN BINDING; RNA SPLICING; RNA-BINDING PROTEINS; SPLICEOSOMES; TRANSFECTION;

MAMMALIA;

EID: 34848823787     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm206     Document Type: Article

References (41)

1. Buchner, D.A., Trudeau, M. and Meisler, M.H. (2003) SCNM1, a putative RNA splicing factor that modifies disease severity in mice. Science 301, 967-969.
2. Kearney, J.A., Buchner, D.A., De Haan, G., Adamska, M., Levin, S.I., Furay, A.R., Albin, R.L., Jones, J.M., Montal, M., Stevens, M.J. et al. (2002) Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6). Hum. Mol. Genet. 11, 2765-2775.
3. Jurica, M.S. and Moore, M.J. (2003) Pre-mRNA splicing: Awash in a sea of proteins. Mol. Cell, 12, 5-14.
4. Lerner, E.A., Lerner, M.R., Janeway, C.A., Jr. and Steitz, J.A. (1981) Monoclonal antibodies to nucleic acid-containing cellular constituents: probes for molecular biology and autoimmune disease. Proc. Natl Acad. Sci. USA, 78, 2737-2741.
5. Cao, W. and Garcia-Blanco, M.A. (1998) A serine/arginine-rich domain in the human U1 70 k protein is necessary and sufficient for ASF/SF2 binding. J. Biol. Chem., 273, 20629-20635.
6. Carrero, G., Hendzel, M.J. and de Vries, G. (2006) Modelling the compartmentalization of splicing factors. J. Theor. Biol., 239 298-312.
7. Lamond, A.I. and Spector, D.L. (2003) Nuclear speckles: A model for nuclear organelles. Nat. Rev. Mol. Cell. Biol., 4, 605-612.
8. Charroux, B., Pellizzoni, L., Perkinson, R.A., Shevchenko, A., Mann, M. and Dreyfuss, G. (1999) Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J. Cell. Biol., 147, 1181-1194.
9. Hoet, R.M., Raats, J.M., de Wildt, R., Dumortier, H., Muller, S., van den Hoogen, F. and van Venrooij, W.J. (1998) Human monoclonal autoantibody fragments from combinatorial antibody libraries directed to the U1snRNP associated U1C protein; epitope mapping, immunolocalization and V-gene usage. Mol. Immunol., 35, 1045-1055.
10. Stanek, D. and Neugebauer, K.M. (2006) The Cajal body: A meeting place for spliceosomal snRNPs in the nuclear maze. Chromosoma, 115 343-354.
11. Fortes, P., Bilbao-Cortes, D., Fornerod, M., Rigaut, G., Raymond, W., Seraphin, B. and Mattaj, I.W. (1999) Luc7p, a novel yeast U1 snRNP protein with a role in 5′ splice site recognition. Genes Dev., 13, 2425-2438.
12. Brahms, H., Raymackers, J., Union, A., de Keyser, F., Meheus, L. and Luhrmann, R. (2000) The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies. J. Biol. Chem., 275, 17122-17129.
13. Kohrman, D.C., Harris, J.B. and Meisler, M.H. (1996) Mutation detection in the med and medJ alleles of the sodium channel Scn8a unusual patterns of exon skipping are influenced by a minor class AT-AC intron. J. Biol. Chem., 271, 17576-17581.
14. Kimura, E., Hidaka, K., Kida, Y., Morisaki, H., Shirai, M., Araki, K., Suzuki, M., Yamamura, K.I. and Morisaki, T. (2004) Serine-arginine-rich nuclear protein Luc7l regulates myogenesis in mice. Gene, 341, 41-47.
15. Umehara, H., Nishii, Y., Morishima, M., Kakehi, Y., Kioka, N., Amachi, T., Koizumi, J., Hagiwara, M. and Ueda, K. (2003) Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A. Biochem. Biophys. Res. Commun., 301, 324-329.
16. Hedley, M.L., Amrein, H. and Maniatis, T. (1995) An amino acid sequence motif sufficient for subnuclear localization of an arginine/serine-rich splicing factor. Proc. Natl Acad. Sci. USA, 92, 11524-11528.
17. Forch, P., Puig, O., Martinez, C., Seraphin, B. and Valcarcel, J. (2002) The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5′ splice sites. Embo J., 21, 6882-6892.
18. Nelissen, R.L., Will, C.L., van Venrooij, W.J. and Luhrmann, R. (1994) The association of the U1-specific 70 K and C proteins with U1 snRNPs is mediated in part by common U snRNP proteins. Embo J., 13, 4113-4125.
19. Du, H. and Rosbash, M. (2002) The U1 snRNP protein U1C recognizes the 5′ splice site in the absence of base pairing. Nature, 419 86-90.
20. Tardiff, D.F. and Rosbash, M. (2006) Arrested yeast splicing complexes indicate stepwise snRNP recruitment during in vivo spliceosome assembly. RNA, 12, 968-979.
21. Fortes, P., Kufel, J., Fornerod, M., Polycarpou-Schwarz, M., Lafontaine, D., Tollervey, D. and Mattaj, I.W. (1999) Genetic and physical interactions involving the yeast nuclear cap-binding complex. Mol. Cell. Biol., 19, 6543-6553.
22. Philipps, D., Celotto, A.M., Wang, Q.Q., Tarng, R.S. and Graveley, B.R. (2003) Arginine/serine repeats are sufficient to constitute a splicing activation domain. Nucleic Acids Res., 31, 6502-6508.
23. Gavin, A.C., Bosche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A., Schultz, J., Rick, J.M., Michon, A.M., Cruciat, C.M. et al. (2002) Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature, 415, 141-147.
24. Zhou, Z., Licklider, L.J., Gygi, S.P. and Reed, R. (2002) Comprehensive proteomic analysis of the human spliceosome. Nature, 419, 182-185.
25. Cazalla, D., Newton, K. and Caceres, J.F. (2005) A novel SR-related protein is required for the second step of Pre-mRNA splicing. Mol. Cell. Biol., 25, 2969-2980.
26. Shipman, K.L., Robinson, P.J., King, B.R., Smith, R. and Nicholson, R.C. (2006) Identification of a family of DNA-binding proteins with homology to RNA splicing factors. Biochem. Cell. Biol., 84, 9-19.
27. Slaugenhaupt, S.A., Blumenfeld, A., Gill, S.P., Leyne, M., Mull, J., Cuajungco, M.P., Liebert, C.B., Chadwick, B., Idelson, M., Reznik, L. et al. (2001) Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am. J. Hum. Genet., 68, 598-605.
28. Nissim-Rafinia, M. and Kerem, B. (2002) Splicing regulation as a potential genetic modifier. Trends Genet., 18, 123-127.
29. Chang, J.G., Hsieh-Li, H.M., Jong, Y.J., Wang, N.M., Tsai, C.H. and Li, H. (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc. Natl Acad. Sci. USA, 98, 9808-9813.
30. Hims, M.M., Ibrahim el, C., Leyne, M., Mull, J., Liu, L., Lazaro, C., Shetty, R.S., Gill, S., Gusella, J.F., Reed, R. et al. (2007) Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia. J. Mol. Med., 85 149-161.
31. Nissim-Rafinia, M., Aviram, M., Randell, S.H., Shushi, L., Ozeri, E., Chiba-Falek, O., Eidelman, O., Pollard, H.B., Yankaskas, J.R. and Kerem, B. (2004) Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. EMBO Rep., 5, 1071-1077.
32. Ayala, Y.M., Pagani, F. and Baralle, F.E. (2006) TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett., 580, 1339-1344.
33. Yang, Y. and Walsh, C.E. (2005) Spliceosome-mediated RNA trans splicing. Mol. Ther., 12, 1006-1012.
34. Kastner, B., Kornstadt, U., Bach, M. and Luhrmann, R. (1992) Structure of the small nuclear RNP particle U1: Identification of the two structural protuberances with RNP-antigens A and 70 K. J. Cell. Biol. 116, 839-849.
35. Vojtek, A.B., Hollenberg, S.M. and Cooper, J.A. (1993) Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell, 74, 205-214.
36. Hollenberg, S.M., Sternglanz, R., Cheng, P.F. and Weintraub, H. (1995) Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol. Cell. Biol., 15, 3813-3822.
37. Fromont-Racine, M., Rain, J.C. and Legrain, P. (2002) Building protein-protein networks by two-hybrid mating strategy. Methods Enzymol., 350, 513-524.
38. Kearney, J.A., Plummer, N.W., Smith, M.R., Kapur, J., Cummins, T.R., Waxman, S.G., Goldin, A.L. and Meisler, M.H. (2001) A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience, 102, 307-317.
39. Buchner, D.A. and Meisler, M.H. (2003) TSRC1, a widely expressed gene containing seven thrombospondin type I repeats. Gene, 307, 23-30.
40. Muto, Y., Pomeranz Krummel, D., Oubridge, C., Hernandez, H., Robinson, C.V., Neuhaus, D. and Nagai, K. (2004) The structure and biochemical properties of the human spliceosomal protein U1C. J. Mol. Biol., 341, 185-198.
41. Levin, S.I. and Meisler, M.H. (2004) Floxed allele for conditional inactivation of the voltage-gated sodium channel Scn8a (NaV1.6). Genesis, 39, 234-239